Logo NANOPILOT PROJECT

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub

(Nanowerk News) A major step in implementing the ETPN Translation Hub has been reached, with three European projects entering the finalisation stage of their EU Grant Agreements. The project ENATRANS is for networking of SMEs in the nano-biomedical sector and supporting the SMEs with getting their products from the laboratory phase to the clinical applications. The projects 'NANOFACTURING' and 'NANOPILOT' will establish pilot lines to scale-up the production of novel nanopharmaceuticals from the lab-scale to the quantities needed for clinical testing. This announcement took place during the ETPN Annual Event 2014 in San Sebastian, Spain.

The ENATRANS project (Enabling NAnomedicine TRANSlation) will ensure the global coherence of the Translation Hub and build a functioning supply chain of nanomedicine projects mainly ran by SMEs and ready to meet industrial and clinical needs. A Translational Advisory Board (TAB) will serve as the cornerstone to provide specific advice, guidance and recommendations to all nanomedicine actors dealing with translation issues and in need of assistance in specific areas of expertise.

Coordinator: ETPN Secretariat c/o VDI/VDE-IT (DE). Consortium: Nanobiotix (FR), CEA-Leti (FR), Bioanalytik Muenster e.V. (DE), Tel-Aviv University (IL), Fondazione Don Carlo Gnocchi ONLUS (IT), and TecMinho (PT).

Duration: 3 years – Budget: €2 Mio.

The NanoFacturing project has two principal objectives. Firstly to scale up an existing Good Manufacturing Practice (GMP) pilot line to a medium scale sustainable manufacturing process for solid core nanopharmaceuticals with a primary focus on glycan-coated gold nanoparticles. The process will also support consortium partners’ clinical programs such as IFOM’s antiviral Dengue fever NP and other EU-wide nanomedicine programs. Secondly to create a large scale process platform that would serve as the basis for GMP compliant industrial manufacture and that will be available as a model for other European companies wishing to develop their own products.

Coordinator: Midatech Biogune (ES). Consortium: Centre for Process Innovation Limited (UK), Prochimia Surfaces SP.Z.O.O (PL), Galchimia S.A (ES), the University College Dublin and the National University of Ireland (IE), Applus S.A. LGAI Technological Center, S.A (ES), IFOM, Fondazione Istituto FIRC di Oncologia Molecolare (IT), and Ecole Polytechnique Federale de Lausanne (CH).

Duration: 4 years – Budget: €8 Mio.

 

The NanoPilot project will build a pilot line for the production of polymer based nanopharmaceuticals in compliance with GMP. The size of the plant aims to be very small, with three systems to be produced at the end of the project. Continuous flow microreactors will be employed for two of the nanopharmaceuticals to be manufactured.

 

Coordinator: the Research Centre IK4-CIDETEC (ES). Consortium : A Research Institute - UT2A-ADERA (FR); two Universities - National University of Ireland, Galway (IE) and Universidad de Santiago de Compostela (ES) ; two industries - Sylentis (ES) and Chemtrix (NL) ; and three SMEs - iX-Factory (DE), Mejoran (ES) and Spinverse (FI).

 

Duration: 4 years – Budget: €6.28 Mio.

 

Patrick Boisseau, chairman of the ETPN, added: “We are very proud to announce such important news during the ETPN Annual Event 2014. The success of the EU calls – 18 proposals have been received for pilot lines for upscaling the manufacturing of nanopharmaceuticals - shows the adequacy of ETPN recommendations with real SMEs needs. We also look forward for the perspectives on a nano-characterisation infrastructure, another major pillar of the Translation Hub asked by European nanomedicine actors. The ETPN is excited to work hand in hand with the different coordinators for a global coherence of actions and a more efficient European value chain in nanomedicine.”

The ETPN Annual Event 2014 is taking place in San Sebastian (Spain) from October 15th to 16th, kindly co-organised by the nanoBasque Agency (SPRI) and hosted by CIC nanoGUNE, the Basque nanoscience cooperative research centre.

 Source: VDI/VDE

05 October, 2017 · Overview

CIDETEC faces the new era of Nanomedicine

More than two decades of intensive basic research on nanomedicine has generated good knowledge on the limitations and the benefits of the use of nanotechnology in the biomedical field. Private and public initiatives have been launched to overcome technical difficulties that limit the translation of basic knowledge on nanomedicine into new products. At this stage, it is essential to gather the attention of nanotechnologists, clinicians, regulators and pharma industry to link bench to bed.
This has been the objective of the 2nd Workshop on translational nanomedicine organized by CIDETEC Nanomedicine in the frame of EC funded NanoPilot project. Would you like to know how it was ? Go to the video of the event in our website: http://www.cidetec.es/2wtn/ Read more

31 August, 2017 · Overview

2nd WORKSHOP ON TRANSLATIONAL NANOMEDICINE (September 18-19_Donostia-San Sebastian)

NanoPilot project is organizing the 2nd Workshop on Translational Nanomedicine that will be held in Donostia-San Sebastian on the 18th and 19th of September, 2017. More information in: http://www.cidetec.es/2wtn/ Read more

07 June, 2017 · Overview

NANOPILOT project present in the 37th Symposium of AEFI (Spanish Association of Pharmaceutical Industry).

NANOPILOT project present in the 37th Symposium of AEFI (Spanish Association of Pharmaceutical Industry) that is held in Barcelona (Spain) 7th-8th of June 2017. Title of the presentation: “PROYECTO NANOPILOT: Diseño y puesta en marcha de una Planta Piloto de producción de nano fármacos en un entorno GMP”. Read more

22 December, 2016 · Overview

NanoPilot Project coordinator was interviewed for a News programme in ETB (A Basque Country Television Channel)

Basque Television ETB 's News programme of 17 and 18 December interviewed Iraida Loinaz about nanomedicine and NanoPilot project objectives. Read more

25 November, 2016 · Overview

Interview to two partners of the NanoPilot consortium-Cincodias newsletter

El que será el primer laboratorio español con capacidad para producir nanofármacos ya se está construyendo en San Sebastián. Las obras concluirán en febrero y, si todo va sobre lo previsto, conseguirá acreditarse para empezar a funcionar a mediados de año. Llama la atención que un país pionero en nanomedicina nunca haya sido capaz de acabar el proceso entero. Hasta ahora, las ayudas a la investigación en esta materia estaban muy enfocadas al desarrollo de la I+D. Faltaba el último empujón para no tener que llevarse la producción al extranjero. Read more